Terms: = Cervical cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
150 results:
1. High p16ink4a Expression, Keratinizing Features, and Surgical Margin-Free Status are Associated with Improved Survival in Patients with Oral Squamous Cell Carcinomas.
Anwar SL; Dwianingsih EK; Lestari SP; Sugandhi W; Cahyono R; Pradana GD
Asian Pac J Cancer Prev; 2024 Mar; 25(3):857-865. PubMed ID: 38546068
[TBL] [Abstract] [Full Text] [Related]
2. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical markers Ki67 and p16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract] [Full Text] [Related]
4. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
5. Is HPV-negative cervical carcinoma a different type of cervical cancer?
Kulhan M; Bilgi A; Avci F; Ucar MG; Celik C; Kulhan NG
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9205-9212. PubMed ID: 37843334
[TBL] [Abstract] [Full Text] [Related]
6. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract] [Full Text] [Related]
7. Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal cancer prognosis.
Fujita Y; Fukuda Y; Sanuki F; Irei I; Monobe Y; Uno M; Akisada T; Shimoya K; Hara H; Moriya T
Head Neck Pathol; 2023 Sep; 17(3):658-672. PubMed ID: 37486532
[TBL] [Abstract] [Full Text] [Related]
8. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
9. Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer.
Amin FAS; Un Naher Z; Ali PSS
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8077-8086. PubMed ID: 37000261
[TBL] [Abstract] [Full Text] [Related]
10. Expression of fascin in association with p16 and Ki-67 in cervical lesions: immunohistochemical study.
Csizmár S; Výbohová D; Mešt'anová V; Krajňáková B; Kajo K; Kunertová L; Adamkov M
Pol J Pathol; 2022; 73(3):208-214. PubMed ID: 36734435
[TBL] [Abstract] [Full Text] [Related]
11. MTA1 as negative prognostic marker in vulvar carcinoma.
Wanka G; Jueckstock J; Wild CM; Vattai A; Fürst S; Heidegger HH; Kuhn C; Schmoeckel E; Jeschke U; Dannecker C
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6191-6201. PubMed ID: 36689059
[TBL] [Abstract] [Full Text] [Related]
12. Utility of high-risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid-based preparations from metastatic head and neck squamous cell carcinoma.
Velez Torres JM; Alkathery T; Tjendra Y; Zuo Y; Kerr DA; Gomez-Fernandez C
Cancer Cytopathol; 2023 Mar; 131(3):165-170. PubMed ID: 36350307
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of CD4
Chen G; Iwata T; Sugawara M; Nishio H; Katoh Y; Kukimoto I; Aoki D
J Gynecol Oncol; 2023 Jan; 34(1):e2. PubMed ID: 36245223
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.
Morse RT; Beaty B; Scanga L; Blumberg J; Patel S; Yarbrough WG; Lumley C; Hackman T; Shen C; Gupta GP; Chera BS
Oral Oncol; 2022 Nov; 134():106131. PubMed ID: 36191480
[TBL] [Abstract] [Full Text] [Related]
15. Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review.
Lu J; Li Y; Wang J
Front Cell Infect Microbiol; 2022; 12():916506. PubMed ID: 35909972
[TBL] [Abstract] [Full Text] [Related]
16. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
17. High-risk human papillomavirus testing in cytology aspiration samples from the head and neck part 2: a survey of the American Society of Cytopathology community.
van Zante A; Flanagan MB; Floyd AD; Johnson DN; Manucha V; McGrath CM; VandenBussche CJ; Griffith CC;
J Am Soc Cytopathol; 2022; 11(5):306-312. PubMed ID: 35850973
[TBL] [Abstract] [Full Text] [Related]
18. Integrative Analyses of m6A Regulators Identify that METTL3 is Associated with HPV Status and Immunosuppressive Microenvironment in HPV-related cancers.
Yu R; Wei Y; He C; Zhou P; Yang H; Deng C; Liu R; Wu P; Gao Q; Cao C
Int J Biol Sci; 2022; 18(9):3874-3887. PubMed ID: 35813476
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathological features of mixed cervical carcinoma with adenoid cystic pattern].
Li LL; Cui YY; Gao PY; Xia L; Liu GZ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):615-620. PubMed ID: 35785831
[No Abstract] [Full Text] [Related]
20. Invasive stratified mucin-producing carcinoma (ISMC) of uterine cervix: description of pathological findings and prognosis factors in a series of 15 Chinese patients.
Lin T; Wang W; Xu L; He Y
Arch Gynecol Obstet; 2022 Nov; 306(5):1703-1709. PubMed ID: 35394200
[TBL] [Abstract] [Full Text] [Related]
[Next]
